Literature DB >> 8488847

Molecular topography of the secondary constriction region (qh) of human chromosome 9 with an unusual euchromatic band.

R S Verma1, S Luke, J P Brennan, T Mathews, R A Conte, M J Macera.   

Abstract

Heterochromatin confined to pericentromeric (c) and secondary constriction (qh) regions plays a major role in morphological variation of chromosome 9, because of its size and affinity for pericentric inversion. Consequently, pairing at pachytene may lead to some disturbances between homologous chromosomes having such extreme variations and may result in abnormalities involving bands adjacent to the qh region. We encountered such a case, where a G-positive band has originated de novo, suggesting a maternal origin from the chromosome 9 that has had a complete pericentric inversion. In previously reported cases, the presence of an extra G-positive band within the 9qh region has been familial, and in the majority of those cases it was not associated with any clinical consequences. Therefore, this anomaly has been referred to as a "rare" variant. The qh region consists of a mixture of various tandemly repeated DNA sequences, and routine banding techniques have failed to characterize the origin of this extra genetic material. By the chromosome in situ suppression hybridization technique using whole chromosome paint, the probe annealed with the extra G-band, suggesting a euchromatic origin from chromosome 9, presumably band p12. By the fluorescence in situ hybridization technique using alpha- and beta-satellite probes, the dicentric nature was further revealed, supporting the concept of unequal crossing-over during maternal meiosis I, which could account for a duplication of the h region. The G-positive band most likely became genetically inert when it was sandwiched between two blocks of heterochromatin, resulting in a phenotypically normal child. Therefore, an earlier hypothesis, suggesting its origin from heterochromatin through so-called euchromatinization, is refuted here.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8488847      PMCID: PMC1682060     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  46 in total

1.  TaqI digestion reveals fractions of satellite DNAs on human chromosomes.

Authors:  I Tagarro; J J González-Aguilera; A M Fernández-Peralta
Journal:  Genome       Date:  1991-04       Impact factor: 2.166

Review 2.  Chromatin as an essential part of the transcriptional mechanism.

Authors:  G Felsenfeld
Journal:  Nature       Date:  1992-01-16       Impact factor: 49.962

3.  A human chromosome 9-specific alphoid DNA repeat spatially resolvable from satellite 3 DNA by fluorescent in situ hybridization.

Authors:  M Rocchi; N Archidiacono; D C Ward; A Baldini
Journal:  Genomics       Date:  1991-03       Impact factor: 5.736

4.  Dinucleotide repeat polymorphism at the D9S55 locus.

Authors:  V Sharma; D Brown; L Smith; R E Magenis; M Litt
Journal:  Nucleic Acids Res       Date:  1991-07-25       Impact factor: 16.971

5.  Clinical and cytological aspects of sex chromosome activity.

Authors:  E Bühler
Journal:  Hereditas       Date:  1977       Impact factor: 3.271

6.  Position effect variegation in the mouse.

Authors:  B M Cattanach
Journal:  Genet Res       Date:  1974-06       Impact factor: 1.588

7.  Apparently isodicentric but functionally monocentric X chromosome in man.

Authors:  E Therman; G E Sarto; K Patau
Journal:  Am J Hum Genet       Date:  1974-01       Impact factor: 11.025

8.  Dic(21;21) in a Down's syndrome child with an unusual chromosome 9 variant in the mother.

Authors:  J M Berg; H A Gardner; R J Gardner; E G Goh; V D Markovic; N E Simpson; R G Worton
Journal:  J Med Genet       Date:  1980-04       Impact factor: 6.318

9.  An extra band in human 9qh+ chromosomes.

Authors:  K Madan
Journal:  Hum Genet       Date:  1978-09-19       Impact factor: 4.132

10.  Structural variability of human chromosome 9 in relation to its evolution.

Authors:  I Hansmann
Journal:  Hum Genet       Date:  1976-03-12       Impact factor: 4.132

View more
  7 in total

1.  Chromosome 9qh inversions may not be true inversions.

Authors:  H Rivera; M Gutiérrez-Angulo; J R González-Garcia
Journal:  Hum Genet       Date:  1999 Jul-Aug       Impact factor: 4.132

2.  An extra band within the human 9qh+ region that behaves like the surrounding constitutive heterochromatin.

Authors:  J L Fernández; S Pereira; A Campos; J Gosálvez; V Goyanes
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

3.  Rare variants of chromosome 9 with extra G positive band within the qh region are not alike.

Authors:  R A Conte; S Gupta; J P Brennan; R S Verma
Journal:  J Med Genet       Date:  1995-05       Impact factor: 6.318

4.  Breakpoints in alpha, beta, and satellite III DNA sequences of chromosome 9 result in a variety of pericentric inversions.

Authors:  K H Ramesh; R S Verma
Journal:  J Med Genet       Date:  1996-05       Impact factor: 6.318

5.  Alphoid DNA diversity of a so-called monocentric Robertsonian fusion.

Authors:  S Luke; G Aggarwal; D G Stetka; R S Verma
Journal:  Chromosome Res       Date:  1994-01       Impact factor: 5.239

6.  Counterstained enhancement of TaqI resistant sites after distamycin A/diamidinophenylindole treatment.

Authors:  R A Conte; R S Verma
Journal:  Histochemistry       Date:  1994-12

7.  Heteromorphic variants of chromosome 9.

Authors:  Nadezda Kosyakova; Ani Grigorian; Thomas Liehr; Marina Manvelyan; Isabella Simonyan; Hasmik Mkrtchyan; Rouben Aroutiounian; Anna D Polityko; Anna I Kulpanovich; Tatiana Egorova; Evgenia Jaroshevich; Alla Frolova; Natalia Shorokh; Irina V Naumchik; Marianne Volleth; Isolde Schreyer; Heike Nelle; Markus Stumm; Rolf-Dieter Wegner; Gisela Reising-Ackermann; Martina Merkas; Lukretija Brecevic; Thomas Martin; Laura Rodríguez; Samarth Bhatt; Monika Ziegler; Katharina Kreskowski; Anja Weise; Ali Sazci; Svetlana Vorsanova; Marcelo de Bello Cioffi; Emel Ergul
Journal:  Mol Cytogenet       Date:  2013-04-01       Impact factor: 2.009

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.